Combination of host susceptibility and virulence of mycobacterium tuberculosis determines dual role of nitric oxide in the protection and control of inflammation

Journal of Infectious Diseases

Volumn 199, Issue 8, 2009, Pages 1222-1232

  Beisiegel, Martin ^a   Kursar, Mischo ^a   Koch, Markus ^a,d   Loddenkemper, Christoph ^b,c   Kuhlmann, Stefanie ^a   Zedler, Ulrike ^a   Stäber, Manuela ^a   Hurwitz, Robert ^a   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Research Center ImmunoSciences   (Germany)

^d Target Discovery (Transgenic and Specialized In Vivo Pharmacology)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CONTROLLED STUDY; HOST RESISTANCE; HOST SUSCEPTIBILITY; INFLAMMATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; TUBERCULOSIS, PULMONARY; VIRULENCE;

EID: 65649118534     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/597421     Document Type: Article

References (50)

1. Kaufmann SH. Tuberculosis and AIDS: a devilish liaison. Drug Discov Today 2007; 12:891-3.
2. Kaufmann SHE. Tuberculosis: back on the immunologists' agenda. Immunity 2006; 24:351-7.
3. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 2007; 7:328-37.
4. Sinsimer D, Huet G, Manca C, et al.The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect Immun 2008; 76:3027-36.
5. Nicol MP, Wilkinson RJ. The clinical consequences of strain diversity in Mycobacterium tuberculosis. Trans R Soc Trop Med Hyg 2008; 102:955-65.
6. Kaufmann SH. Tuberculosis: deadly combination. Nature 2008; 453: 295-6.
7. Gómez LM, Anaya JM, Ramon Vilchez J, et al.A polymorphism in the inducible nitric oxide synthase gene is associated with tuberculosis. Tuberculosis (Edinb) 2007; 87:288-94.
8. Caws M, Thwaites G, Dunstan S, et al.The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog 2008; 4:e1000034.
9. Flynn JL. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect 2006; 8:1179-88.
10. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
11. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A 1997; 94:5243-8.
12. Flesch IE, Kaufmann SH. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun 1991; 59: 3213-8.
13. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 2000; 97:8841-8.
14. Nozaki Y, Hasegawa Y, Ichiyama S, Nakashima I, Shimokata K. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun 1997; 65:3644-7.
15. Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, Kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 1998; 11:809-15.
16. Schon T, Elmberger G, Negesse Y, Pando RH, Sundqvist T, Britton S. Local production of nitric oxide in patients with tuberculosis. Int J Tuberc Lung Dis 2004; 8:1134-7.
17. Steenken W Jr, Gardner LU. History of H37 strain of tubercle bacillus. Am Rev Tuberc 1946; 54:62-6.
18. Lee JS, Krause R, Schreiber J, et al.Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain. Cell Host Microbe 2008; 3:97-103.
19. Gonzalo-Asensio J, Mostowy S, Harders-Westerveen J, et al.PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. PLoS ONE 2008; 3:e3496.
20. Jung YJ, LaCourse R, Ryan L, North RJ. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice. J Exp Med 2002; 196:991-8.
21. Zhang J, Jiang R, Takayama H, Tanaka Y. Survival of virulent Mycobacterium tuberculosis involves preventing apoptosis induced by Bcl-2 upregulation and release resulting from necrosis in J774 macrophages. Microbiol Immunol 2005; 49:845-52.
22. Chen M, Gan H, Remold HG. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol 2006; 176:3707-16.
23. Braig M, Lee S, Loddenkemper C, et al.Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436:660-5.
24. Irwin SM, Izzo AA, Dow SW, et al.Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyprotein. Infect Immun 2005; 73:5809-16.
25. Kursar M, Koch M, Mittrucker HW, et al.Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 2007; 178:2661-5.
26. Zelenay S, Lopes-Carvalho T, Caramalho I, Moraes-Fontes MF, Rebelo M, Demengeot J. Foxp3- CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc Natl Acad Sci U S A 2005; 102:4091-6.
27. Freeman S, Post FA, Bekker LG, et al.Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro. J Interferon Cytokine Res 2006; 26:27-33.
28. Kaufmann SH. How can immunology contribute to the control of tuberculosis? Nat Rev Immunol 2001; 1:20-30.
29. Sud D, Bigbee C, Flynn JL, Kirschner DE. Contribution of CD8- T cells to control of Mycobacterium tuberculosis infection. J Immunol 2006; 176:4296-314.
30. van Pinxteren LA, Cassidy JP, Smedegaard BH, Agger EM, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 2000; 30:3689-98.
31. Bourgarit A, Carcelain G, Martinez V, et al.Explosion of tuberculinspecific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006; 20:F1-7.
32. Martineau AR, Newton SM, Wilkinson KA, et al.Neutrophilmediated innate immune resistance to mycobacteria. J Clin Invest 2007; 117:1988-994.
33. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006; 6:173-82.
34. Seiler P, Aichele P, Raupach B, Odermatt B, Steinhoff U, Kaufmann SH. Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. J Infect Dis 2000; 181:671-80.
35. Gil O, Guirado E, Gordillo S, et al.Intragranulomatous necrosis in lungs of mice infected by aerosol with Mycobacterium tuberculosis is related to bacterial load rather than to any one cytokine or T cell type. Microbes Infect 2006; 8:628-36.
36. Perskvist N, Long M, Stendahl O, Zheng L. Mycobacterium tuberculosis promotes apoptosis in human neutrophils by activating caspase-3 and altering expression of Bax/Bcl-xL via an oxygen-dependent pathway. J Immunol 2002; 168:6358-65.
37. Koul A, Herget T, Klebl B, Ullrich A. Interplay between mycobacteria and host signalling pathways. Nat Rev Microbiol 2004; 2:189-202.
38. Rohde K, Yates RM, Purdy GE, Russell DG. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev 2007; 219: 37-54.
39. Axelrod S, Oschkinat H, Enders J, et al.Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide. Cell Microbiol 2008; 10:1530 - 45.
40. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8:279-89.
41. Erjefalt J. Transepithelial migration, necrosis and apoptosis as silent and pro-inflammatory fates of airway granulocytes. Curr Drug Targets Inflamm Allergy 2005; 4:425-31.
42. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007; 13:851-6.
43. van Raam BJ, Drewniak A, Groenewold V, van den Berg TK, Kuijpers TW. Granulocyte colony-stimulating factor delays neutrophil apoptosis by inhibition of calpains upstream of caspase-3. Blood 2008; 112:2046-54.
44. Call DR, Nemzek JA, Ebong SJ, et al.Differential local and systemic regulation of the murine chemokines KC and MIP2. Shock 2001; 15: 278-84.
45. Shibata T, Nagata K, Kobayashi Y. A suppressive role of nitric oxide in MIP-2 production by macrophages upon coculturing with apoptotic cells. J Leukoc Biol 2006; 80:744-52.
46. Rios-Santos F, Alves-Filho JC, Souto FO, et al.Down-regulation of CXCR2 on neutrophils in severe sepsis is mediated by inducible nitric oxide synthase- derived nitric oxide. Am J Respir Crit Care Med 2007; 175:490-7.
47. Shibata T, Nagata K, Kobayashi Y. Cutting edge: a critical role of nitric oxide in preventing inflammation upon apoptotic cell clearance. J Immunol 2007; 179:3407-11.
48. Tanimoto N, Terasawa M, Nakamura M, et al.Involvement of KC, MIP-2, and MCP-1 in leukocyte infiltration following injection of necrotic cells into the peritoneal cavity. Biochem Biophys Res Commun 2007; 361:533-6.
49. Goncalves AS, Appelberg R. The involvement of the chemokine receptor CXCR2 in neutrophil recruitment in LPS-induced inflammation and in Mycobacterium avium infection. Scand J Immunol 2002; 55:585-91.
50. Morris A, Kinnear G, Wan WY, Wyss D, Bahra P, Stevenson CS. Comparison of cigarette smoke-induced acute inflammation in multiple strains of mice and the effect of an MMP inhibitor on these responses. J Pharmacol Exp Ther 2008; 327:851-62.